When Rob, an avid cyclist, learned he had inherited a rare genetic heart condition that increased his risk of sudden cardiac arrest, he feared that his days of...

With the growing prevalence of neurological disorders, from Parkinson’s disease and chronic pain to Alzheimer’s disease, rapid innovation in neuromodulation – a medical approach to treating conditions related to the brain and nervous system – is more important than ever.

By Dr. Ian Meredith, global chief medical officer, Boston Scientific October 12, 2021 In the next two decades, the global population over age 65 is expected to increase exponentially. With this...

For the last 30 years, Jenny Levinson, a leader in the Boston Scientific Health Economics and Market Access (HEMA) group, has worked to ensure that patients have access to...

Increasing patient safety. Improving clinical outcomes. Enabling rapid innovation. These are just a few of the many benefits fuelling the trend toward single-use devices in the field of endoscopy....